The relationship between affect balance style and clinical outcomes in fibromyalgia

Arthritis Care and Research

Volumn 59, Issue 6, 2008, Pages 833-840

  Hassett, Afton L ^a   Simonelli, Laura E ^a,b   Radvanski, Diane C ^a   Buyske, Steven ^c   Savage, Shantal V ^a   Sigal, Leonard H ^a,d  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFFECT; AGED; ARTICLE; COMORBIDITY; DEPRESSION; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PHYSICAL EXAMINATION; QUESTIONNAIRE; SCREENING; STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; AFFECT; AGED; DEPRESSION; FEMALE; FIBROMYALGIA; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED;

EID: 45349096666     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23708     Document Type: Article

References (55)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
3. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006;67:1219-25.
4. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia: a multicenter investigation. Psychosomatics 1999;40:57-63.
5. Hassett AL, Cone JD, Patella SJ, Sigal LH. The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 2000;43:2493-500.
6. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004;50:944-52.
7. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999;6:433-9.
8. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999;42:2482-8.
9. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 2004;110:449-60.
10. Staud R, Price DD, Robinson ME, Vierck CJ Jr. Body pain area and pain-related negative affect predict clinical pain intensity in patients with fibromyalgia. J Pain 2004;5:338-43.
11. Staud R, Vierck CJ, Robinson ME, Price DD. Overall fibromyalgia pain is predicted by ratings of local pain and pain-related negative affect: possible role of peripheral tissues. Rheumatology (Oxford) 2006;45:1409-15.
12. Finset A, Wigers SH, Gotestam KG. Depressed mood impedes pain treatment response in patients with fibromyalgia. J Rheumatol 2004;31:976-80.
13. Zautra AJ, Johnson LM, Davis MC. Positive affect as a source of resilience for women in chronic pain. J Consult Clin Psychol 2005;73:212-20.
14. Nicassio PM, Schuman C. The prediction of fatigue in fibromyalgia. J Musculoskelet Pain 2005;13:15-25.
15. Zautra AJ, Fasman R, Parish BP, Davis MC. Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Pain 2007;128:128-35.
16. Kassam A, Patten SB. Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study. BMC Musculoskelet Disord 2006;7:4.
17. Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993;20:475-9.
18. Zautra A, Smith B, Affleck G, Tennen H. Examinations of chronic pain and affect relationships: applications of a dynamic model of affect. J Consult Clin Psychol 2001;69:786-95.
19. Zautra AJ, Fasman R, Reich JW, Harakas P, Johnson LM, Olmsted ME, et al. Fibromyalgia: evidence for deficits in positive affect regulation. Psychosom Med 2005;67:147-55.
20. Pressman SD, Cohen S. Does positive affect influence health? Psychol Bull 2005;131:925-71.
21. Bradburn NM. The structure of psychological well-being. Chicago: Aldine; 1969.
22. Kim KA, Mueller DJ. To balance or not to balance: confirmatory factor analysis of the Affect-Balance Scale. J Happiness Stud 2001;2:289-306.
23. Macintosh R. A confirmatory factor analysis of the Affect Balance Scale in 38 nations: a research note. Soc Psychol Q 1998;61:83-95.
24. Schwartz RM, Garamoni GL. Cognitive balance and psychopathology: evaluation of an information processing model of positive and negative states of mind. Clin Psychol Rev 1989;9:271-94.
25. Fredman L, Hawkes WG, Black S, Bertrand RM, Magaziner J. Elderly patients with hip fracture with positive affect have better functional recovery over 2 years. J Am Geriatr Soc 2006;54:1074-81.
26. Moskowitz JT. Positive affect predicts lower risk of AIDS mortality. Psychosom Med 2003;65:620-6.
27. Strand EB, Zautra AJ, Thoresen M, Odegard S, Uhlig T, Finset A. Positive affect as a factor of resilience in the pain-negative affect relationship in patients with rheumatoid arthritis. J Psychosom Res 2006;60:477-84.
28. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:1063-70.
29. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728-33.
30. Fallon J, Bujak DI, Guardino S, Weinstein A. The Fibromyalgia Impact Questionnaire: a useful tool in evaluating patients with post-Lyme disease syndrome. Arthritis Care Res 1999;12:42-7.
31. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-56.
32. First MB, Gibbon M, Spitzer RL, Williams JB. User's guide for the structured clinical interview for DSM-IV axis I disorders: research version (SCID-I, version 2.0, February 1996 final version). Washington (DC): American Psychiatric Press; 1996.
33. Steiner JL, Tebes JK, Sledge WH, Walker ML. A comparison of the structured clinical interview for DSM-III-R and clinical diagnoses. J Nerv Ment Dis 1995;18:365-9.
34. Zanarini MC, Frankenburg FR. Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry 2001;42:369-74.
35. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Recomm Rep 1990;39:1-43.
36. SPSS for Windows, version 14.0.0. Chicago: SPSS; 2005.
37. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2007.
38. Wright SP. Adjusted P-values for simultaneous inference. Biometrics 1992;48:1005-13.
39. Porter-Moffitt S, Gatchel RJ, Robinson RC, Deschner M, Posamentier M, Polatin P, et al. Biopsychosocial profiles of different pain diagnostic groups. J Pain 2006;7:308-18.
40. Suhr JA. Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 2003;55:321-9.
41. Palomino RA, Nicassio PM, Greenberg MA, Medina EP Jr. Helplessness and loss as mediators between pain and depressive symptoms in fibromyalgia. Pain 2007;129:185-94.
42. Crawford JR, Henry JD. The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol 2004;43:245-65.
43. McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav 2003;43:2-15.
44. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005;67 Suppl 1:S26-8.
45. Agelink MW, Majewski T, Wurthmann C, Postert T, Linka T, Rotterdam S, et al. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. J Affect Disord 2001;62:187-98.
46. Sarzi-Puttini P, Atzeni F, Diana A, Doria A, Furlan R. Increased neural sympathetic activation in fibromyalgia syndrome. Ann N Y Acad Sci 2006;1069:109-17.
47. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, et al. Fibromyalgia syndrome. J Rheumatol 2007;34:1415-25.
48. Dadabhoy D, Clauw DJ. Fibromyalgia: progress in diagnosis and treatment. Curr Pain Headache Rep 2005;9:399-404.
49. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997;4:134-53.
50. Martinez-Lavin M. Fibromyalgia as a sympathetically maintained pain syndrome [review]. Curr Pain Headache Rep 2004;8:385-9.
51. DeMaria S Jr, Hassett AL, Sigal LH. N-methyl-D-aspartate receptor-mediated chronic pain: new approaches to fibromyalgia syndrome etiology and therapy. J Musculoskelet Pain 2007;15:33-44.
52. Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003;48:2916-22.
53. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 2004;66:837-44.
54. Hassett AL, Maclean JR, Stuart MR, Peterson C, Buyske S, Park N, et al. Further validation for the observational evaluation of psychological well-being in rheumatoid arthritis: data from the ATTAIN study [abstract]. Ann Rheum Dis 2007;66 Suppl 2:121.
55. Hassett AL, Simonelli LE, Radvanski DC, Savage SV, Sigal LH. Affect balance and catastrophizing in patients with fibromyalgia (FM) [abstract]. Arthritis Rheum 2007;56 Suppl 9:S531.